MycoMedica Life Sciences, PBC | psilocybin medicines
MycoMedica Life Sciences, PBC | psilocybin medicines
Description: KittyHawk Ventures is a Los Angeles based venture capital firm founded by Will Weisman. KittyHawk is a frontier / deep tech investor with a focus on seed stage investments in Health (longevity, life sciences, medical devices) computing (AI / Quantum / networks / sensors), ClimateTech, aerospace, Web3 and more. KittyHawk supports world changing entrepreneurs who are mission driven to solve problems that support people and the planet and move our world forward.
KittyHawk Ventures was founded by Will Weisman in 2015 at Singularity University and named after Kitty Hawk, North Carolina where the Wright Brothers flew the world’s first airplane and launched a new era in human mobility.
Singularity University, located at the NASA Ames Research Park in Silicon Valley, is a place that has witnessed the birth of new technologies, new industries and new chapters in human achievement and this access to leading innovation inspired the launch of KittyHawk, a frontier technology focused venture fund.
For almost seven years, Will served as an Executive Director at Singularity where he helped lead the organization and build and run the large summits around the world. As a platform with chapters in 159+ countries, and over 200k community members, SU provides extraordinary access to what is happening at the forefront of technological change along with the opportunity to connect with some of the world’s leading scientists, academics, investors, entrepreneurs, business executives and government officials.
MycoMedica Life Sciences, PBC | psilocybin medicines
MycoMedica Life Sciences, PBC | psilocybin medicines